Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: Combined effect for both infections, an obtainable goal?

1999-05-01

Antiviral Research , Volume 42 - Issue 1 p. 71- 76

Additional Metadata
Keywords	Hepatitis B virus, Human immunodeficiency virus, Lamivudine, Lamivudine withdrawal hepatitis, Resistance, Triple therapy
Persistent URL	doi.org/10.1016/S0166-3542(99)00016-9, hdl.handle.net/1765/66365
Journal	Antiviral Research
Organisation	Department of Virology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Wolters, L., Niesters, B., de Man, R., & Schalm, S. (1999). Antiviral treatment for human immunodeficiency virus patients co-infected with hepatitis B virus: Combined effect for both infections, an obtainable goal?. Antiviral Research, 42(1), 71–76. doi:10.1016/S0166-3542(99)00016-9

Publication